← Leaderboards
Cynthia J. Tifft
Children'S Research Institute
$56,481
Attributed
$56,481
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $18.6K · FY2006–10$20K$15K$10K$5K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$56,481 · 5
By mechanism
M01$56,481 · 5
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Kevin Robert Cleary$15,677,966
- Diana M Escolar$932,040
- Lawrence D'angelo$13,627,486
- Yue Chen$1,729,925
- Karun V Sharma$2,162,173
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingSourceGrantSafetyComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionResourcesUnited States National Institutes Of HealthResearch PersonnelHourIntravenousMiglustatModificationNeedlestick InjuriesPlacementProtocols DocumentationRecruitment ActivityZavescaBloodCase-BasedCathetersChildCountryDiagnosis
Grant awards (5)
AN EXPLORATORY, OPEN-LABEL STUDY OF THE SAFETY AND$18,594
M01 · FY2010 · RR · contact PI
PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ZAVESCA (MIGLUSTAT) IN PATIENTS$17,113
M01 · FY2008 · RR · contact PI
PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ZAVESCA (MIGLUSTAT) IN PATIENTS$7,945
M01 · FY2007 · RR · contact PI
PATHOGENESIS AND NATURAL HISTORY OF THE GLYCOSPHINGOLIPD (GSL) STORAGE$10,764
M01 · FY2006 · RR · contact PI
PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ZAVESCA (MIGLUSTAT) IN PATIENTS$2,065
M01 · FY2006 · RR · contact PI